Evidence map›Paper›PMID 35705273›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Portal Vein Thrombosis as a Cause of Undetermined Thrombocytopenia with Liver Dysfunction in a Patient with Eosinophilic Granulomatosis with Polyangiitis.

Naoya Oka, Yusuke Yoshida, Tomohiro Sugimoto, Ai Yorishima, Sho Masuda, Shintaro Hirata

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. [Clinicopathological characteristics and key therapeutic options for liver involvement with vasculitis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Naoya OkaDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.
Yusuke YoshidaDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.
Tomohiro SugimotoDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.
Ai YorishimaDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.
Sho MasudaDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.
Shintaro HirataDepartment of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.
Hiroshima University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a 20-year-old woman who developed eosinophilic granulomatosis with polyangiitis (EGPA) and portal vein thrombosis (PVT). EGPA was diagnosed based on the patient's history of asthma, hypereosinophilia, and mononeuritis complex. Thrombocytopenia and liver dysfunction were observed, necessitating contrast-enhanced computed tomography (CECT), which revealed PVT. Her symptoms soon improved with glucocorticoids and anticoagulation therapy. As patients with EGPA often suffer from asthma, they can be hesitant to undergo CECT. However, if patients with EGPA show uncertain thrombocytopenia with liver dysfunction, a further evaluation using CECT is warranted to detect PVT.

Indexed as

AsthmaChurg-Strauss SyndromeGranulomatosis with PolyangiitisLeukopeniaLiver DiseasesThrombocytopeniaThrombosisAdultFemaleHumansPortal VeinYoung Adulteosinophilic granulomatosis with polyangiitisliver dysfunctionportal vein thrombosisthrombocytopenia

Identifiers

PMID35705273
PMCPMC9876703
OpenAlexW4283024607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.